Transcatheter pulmonary valve replacement, also known as percutaneous pulmonary valve implantation, is the replacement of the pulmonary valve by way of catheterization through a vein. It is a minimally invasive alternative to conventional open heart surgery, commonly used to address conditions such as pulmonary atresia and used for congenital defects of the right ventricular outflow tract or a failing artificial valve, with reported successful implantation in ninety-two to ninety-eight percent of cases.
Facts
Transcatheter Pulmonary Valve Replacement
Filter Results1 entry
FAQs
Which patients can receive a transcatheter pulmonary valve in the United States?
The Harmony valve is indicated for children and adults with severe pulmonary regurgitation who would otherwise need surgical valve replacement.
The answer depends on the device, because each approved valve has its own indication. The Harmony transcatheter pulmonary valve system, approved by the United States Food and Drug Administration on March 26, 2021, is indicated for pediatric and adult patients with severe pulmonary regurgitation who have a native or surgically repaired right ventricular outflow tract and are clinically indicated for surgical pulmonary valve replacement. Severe regurgitation is defined by echocardiography or by a pulmonary regurgitant fraction of 30 percent or more on cardiac magnetic resonance imaging. This describes one device's regulatory indication and is not medical advice. A cardiology team decides who qualifies.
Connections
Treats
Source Transcatheter pulmonary valve replacement (Wikipedia)
Sources
1. Wikipedia
Wikipedia contributors, Wikimedia Foundation
2. Transcatheter pulmonary valve replacement (Wikipedia)
https://en.wikipedia.org/wiki/Transcatheter_pulmonary_valve_replacement, lead section
ignificantly less invasive procedure in comparison to open heart surgery and is commonly used to treat conditions such as pulmonary atresia.
Section: History (origin-year)
The first TPVR was performed in 2000.
Treats: Tetralogy of Fallot, Uses
TPVR can be used to repair congenital defects in the pulmonary valve or right ventricular outflow tract dysfunction, such as pulmonary atresia, Tetralogy of Fallot, or persistent truncus arteriosus.
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.
View At A Past Year
Choose a year to see this entry's facts and connections as the atlas records them at that moment: what it held then, what it held instead, and what it had not yet adopted. Choose Present for the current record.